# Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia

> **NCT04512105** · PHASE1 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 6 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- AML, Adult
- CLL
- CLL, Relapsed
- CLL, Refractory

## Interventions

- **DRUG:** Pitavastatin
- **DRUG:** Venetoclax

## Key facts

- **NCT ID:** NCT04512105
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-02
- **Primary completion:** 2024-07-20
- **Final completion:** 2025-02-05
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04512105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04512105, "Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04512105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*